170 related articles for article (PubMed ID: 31285276)
1. The estimated healthcare cost of diabetic retinopathy in Indonesia and its projection for 2025.
Sasongko MB; Wardhana FS; Febryanto GA; Agni AN; Supanji S; Indrayanti SR; Widayanti TW; Widyaputri F; Widhasari IA; Lestari YD; Adriono GA; Sovani I; Kartasasmita AS
Br J Ophthalmol; 2020 Apr; 104(4):487-492. PubMed ID: 31285276
[TBL] [Abstract][Full Text] [Related]
2. Rapid assessment of avoidable blindness-based healthcare costs of diabetic retinopathy in Hungary and its projection for the year 2045.
Tóth G; Limburg H; Szabó D; Sándor GL; Nagy ZZ; Németh J
Br J Ophthalmol; 2021 Aug; 105(8):1116-1120. PubMed ID: 32788328
[TBL] [Abstract][Full Text] [Related]
3. Cost Evaluation of Early Vitrectomy versus Panretinal Photocoagulation and Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.
Lin J; Chang JS; Yannuzzi NA; Smiddy WE
Ophthalmology; 2018 Sep; 125(9):1393-1400. PubMed ID: 29606379
[TBL] [Abstract][Full Text] [Related]
4. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.
Vail D; Callaway NF; Ludwig CA; Saroj N; Moshfeghi DM
Am J Ophthalmol; 2019 Nov; 207():378-384. PubMed ID: 31194953
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
[TBL] [Abstract][Full Text] [Related]
6. Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy.
Wykoff CC; Chakravarthy U; Campochiaro PA; Bailey C; Green K; Cunha-Vaz J
Ophthalmology; 2017 Apr; 124(4):440-449. PubMed ID: 28081945
[TBL] [Abstract][Full Text] [Related]
7. Self-reported healthcare utilization by adults with diabetic retinopathy in the United States.
Willis JR; Doan QV; Gleeson M; Haskova Z; Ramulu P; Morse L; Cantrell RA
Ophthalmic Epidemiol; 2018; 25(5-6):365-372. PubMed ID: 29958092
[TBL] [Abstract][Full Text] [Related]
8. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
[TBL] [Abstract][Full Text] [Related]
9. Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore.
Zhang X; Low S; Kumari N; Wang J; Ang K; Yeo D; Yip CC; Tavintharan S; Sum CF; Lim SC
PLoS One; 2017; 12(7):e0180949. PubMed ID: 28700742
[TBL] [Abstract][Full Text] [Related]
10. Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States.
Willis JR; Doan QV; Gleeson M; Haskova Z; Ramulu P; Morse L; Cantrell RA
JAMA Ophthalmol; 2017 Sep; 135(9):926-932. PubMed ID: 28750122
[TBL] [Abstract][Full Text] [Related]
11. Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.
Lin J; Chang JS; Smiddy WE
Ophthalmology; 2016 Sep; 123(9):1912-8. PubMed ID: 27425822
[TBL] [Abstract][Full Text] [Related]
12. Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up.
Romero-Aroca P; de la Riva-Fernandez S; Valls-Mateu A; Sagarra-Alamo R; Moreno-Ribas A; Soler N; Puig D
BMC Ophthalmol; 2016 Aug; 16():136. PubMed ID: 27491545
[TBL] [Abstract][Full Text] [Related]
13. Direct and indirect costs among employees with diabetic retinopathy in the United States.
Lee LJ; Yu AP; Cahill KE; Oglesby AK; Tang J; Qiu Y; Birnbaum HG
Curr Med Res Opin; 2008 May; 24(5):1549-59. PubMed ID: 18416887
[TBL] [Abstract][Full Text] [Related]
14. Trends in Diabetic Retinopathy, Visual Acuity, and Treatment Outcomes for Patients Living With Diabetes in a Fundus Photograph-Based Diabetic Retinopathy Screening Program in Bangladesh.
Muqit MMK; Kourgialis N; Jackson-deGraffenried M; Talukder Z; Khetran ER; Rahman A; Chan WO; Chowdury FA; Nag D; Ahmad J; Friedman DS
JAMA Netw Open; 2019 Nov; 2(11):e1916285. PubMed ID: 31774523
[TBL] [Abstract][Full Text] [Related]
15. Evidence-Based Treatment of Diabetic Retinopathy.
El Rami H; Barham R; Sun JK; Silva PS
Semin Ophthalmol; 2017; 32(1):67-74. PubMed ID: 27700224
[TBL] [Abstract][Full Text] [Related]
16. First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.
Dutra Medeiros M; Mesquita E; Gardete-Correia L; Moita J; Genro V; Papoila AL; Amaral-Turkman A; Raposo JF
Ophthalmology; 2015 Dec; 122(12):2473-81. PubMed ID: 26383994
[TBL] [Abstract][Full Text] [Related]
17. Transition from Laser to Intravitreal Injections for Diabetic Retinopathy: Hospital Utilization and Costs from an Extended Healthcare Perspective.
Hertzberg SNW; Jørstad ØK; Petrovski BÉ; Bragadottir R; Steffensen LA; Moe MC; Burger EA; Petrovski G
Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36231903
[TBL] [Abstract][Full Text] [Related]
18. The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy.
Lee CS; Lee AY; Baughman D; Sim D; Akelere T; Brand C; Crabb DP; Denniston AK; Downey L; Fitt A; Khan R; Mahmood S; Mandal K; Mckibbin M; Menon G; Lobo A; Kumar BV; Natha S; Varma A; Wilkinson E; Mitry D; Bailey C; Chakravarthy U; Tufail A; Egan C;
Am J Ophthalmol; 2017 Aug; 180():64-71. PubMed ID: 28572062
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden.
Heintz E; Wiréhn AB; Peebo BB; Rosenqvist U; Levin LA
Diabetologia; 2010 Oct; 53(10):2147-54. PubMed ID: 20596693
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, progression, and outcomes of diabetic retinopathy during pregnancy in Indian scenario.
Makwana T; Takkar B; Venkatesh P; Sharma JB; Gupta Y; Chawla R; Vohra R; Kriplani A; Tandon N
Indian J Ophthalmol; 2018 Apr; 66(4):541-546. PubMed ID: 29582816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
